Obesity is a known risk factor for cardiovascular disease, but people's weights can shift over time, and little is known ...

Women under 35 who had high cumulative exposure to excess weight saw their risk of heart disease jump by 60%. In contrast, ...

Altimmune said its experimental drug in a midstage trial helped patients shed weight but also minimized the loss of muscle mass. Altimmune is one of several smaller biotech companies pushing to ...

Obesity is a known risk factor for cardiovascular disease, but people's weights can shift over time, and little is known ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that ...

After a full data analysis, Altimmune is heralding phase 2 obesity data for pemvidutide as “best-in-class” for spurring weight loss while preserving lean mass. The small biotech is going up against ...

Individuals stopping GLP-1 receptor agonists regain most lost weight within 1 year, but about one quarter of the weight ...

Adjusted body weight is used to calculate weight, which considers lean and fat mass. This tool can help provide more precise medical and nutritional assessments. Healthcare professionals often use ...